|
1
|
Areia M, Carvalho R, Cadime AT, Rocha
Goncalves F and Dinis-Ribeiro M: Screening for gastric cancer and
surveillance of premalignant lesions: A systematic review of
cost-effectiveness studies. Helicobacter. 18:325–337. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hossain MM and Chen Z: Comments on
‘Application of an adaptive design to a randomized phase II
selection trial in gastric cancer: A report of the study design’ by
Satoshi Morita and Junichi Sakamoto. Pharm Stat. 11:267–268. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pimenta-Melo AR, Monteiro-Soares M,
Libânio D and Dinis-Ribeiro M: Missing rate for gastric cancer
during upper gastrointestinal endoscopy: A systematic review and
meta-analysis. Eur J Gastroenterol Hepatol. 28:1041–1019. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Veisani Y and Delpisheh A: Survival rate
of gastric cancer in Iran; a systematic review and meta-analysis.
Gastroenterol Hepatol Bed Bench. 9:78–86. 2016.PubMed/NCBI
|
|
5
|
Nakajima T, Inokuchi K, Hattori T, Inoue
K, Taguchi T, Kondou T, Abe O, Kikuchi K, Tanabe T and Ogawa N:
Multi-institutional cooperative study of adjuvant
immunochemotherapy in gastric cancer-five-year survival rate. Gan
To Kagaku Ryoho. 16:799–806. 1989.(In Japanese). PubMed/NCBI
|
|
6
|
Jung SA, Park YM, Hong SW, Moon JH, Shin
JS, Lee HR, Ha SH, Lee DH, Kim JH, Kim SM, et al: Cellular
inhibitor of apoptosis protein 1 (cIAP1) stability contributes to
YM155 resistance in human gastric cancer cells. J Biol Chem.
290:9974–9985. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Izawa M, Mori T, Satoh T, Teramachi K and
Sairenji T: Identification of an alternative form of caspase-9 in
human gastric cancer cell lines: A role of a caspase-9 variant in
apoptosis resistance. Apoptosis. 4:321–325. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Moody SE, Schinzel AC, Singh S, Izzo F,
Strickland MR, Luo L, Thomas SR, Boehm JS, Kim SY, Wang ZC and Hahn
WC: PRKACA mediates resistance to HER2-targeted therapy in breast
cancer cells and restores anti-apoptotic signaling. Oncogene.
34:2061–2071. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Shiota M, Yokomizo A and Naito S:
Pro-survival and anti-apoptotic properties of androgen receptor
signaling by oxidative stress promote treatment resistance in
prostate cancer. Endocr Relat Cancer. 19:R243–R253. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yamato I, Sho M, Shimada K, Hotta K, Ueda
Y, Yasuda S, Shigi N, Konishi N, Tsujikawa K and Nakajima Y:
PCA-1/ALKBH3 contributes to pancreatic cancer by supporting
apoptotic resistance and angiogenesis. Cancer Res. 72:4829–4839.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Coccolini F, Catena F, Glehen O, Yonemura
Y, Sugarbaker PH, Piso P, Ceresoli M, Montori G and Ansaloni L:
Effect of intraperitoneal chemotherapy and peritoneal lavage in
positive peritoneal cytology in gastric cancer. Systematic review
and meta-analysis. Eur J Surg Oncol. 42:1261–1267. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li K and Li J: Current molecular targeted
therapy in advanced gastric cancer: A comprehensive review of
therapeutic mechanism, clinical trials, and practical application.
Gastroenterol Res Pract. 2016:41056152016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Marusiak AA, Edwards ZC, Hugo W, Trotter
EW, Girotti MR, Stephenson NL, Kong X, Gartside MG, Fawdar S,
Hudson A, et al: Mixed lineage kinases activate MEK independently
of RAF to mediate resistance to RAF inhibitors. Nat Commun.
5:39012014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Handley ME, Rasaiyaah J, Barnett J,
Thakker M, Pollara G, Katz DR and Chain BM: Expression and function
of mixed lineage kinases in dendritic cells. Int Immunol.
19:923–933. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jaeschke A and Davis RJ: Metabolic stress
signaling mediated by mixed-lineage kinases. Mol Cell. 27:498–508.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Martini M, Russo M, Lamba S, Vitiello E,
Crowley EH, Sassi F, Romanelli D, Frattini M, Marchetti A and
Bardelli A: Mixed lineage kinase MLK4 is activated in colorectal
cancers where it synergistically cooperates with activated RAS
signaling in driving tumorigenesis. Cancer Res. 73:1912–1921. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Seit-Nebi A, Cheng W, Xu H and Han J: MLK4
has negative effect on TLR4 signaling. Cell Mol Immunol. 9:27–33.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Soung YH, Lee JW, Kim SY, Nam SW, Park WS,
Lee JY, Yoo NJ and Lee SH: Kinase domain mutation of MLK4 gene is
uncommon in gastric and hepatocellular carcinomas. Dig Liver Dis.
38:2832006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kim SH, Ezhilarasan R, Phillips E,
Gallego-Perez D, Sparks A, Taylor D, Ladner K, Furuta T, Sabit H,
Chhipa R, et al: Serine/Threonine kinase MLK4 determines
mesenchymal identity in glioma stem cells in an NF-κB-dependent
manner. Cancer Cell. 29:201–213. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Marusiak AA, Stephenson NL, Baik H,
Trotter EW, Li Y, Blyth K, Mason S, Chapman P, Puto LA, Read JA, et
al: Recurrent MLK4 loss-of-function mutations suppress JNK
signaling to promote colon tumorigenesis. Cancer Res. 76:724–735.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kohli M, Rago C, Lengauer C, Kinzler KW
and Vogelstein B: Facile methods for generating human somatic cell
gene knockouts using recombinant adeno-associated viruses. Nucleic
Acids Res. 32:e32004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xiao S, Wang J and Xiao N: MicroRNAs as
noninvasive biomarkers in bladder cancer detection: A diagnostic
meta-analysis based on qRT-PCR data. Int J Biol Markers.
31:e276–e285. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wai-Hoe L, Wing-Seng L, Ismail Z and
Lay-Harn G: SDS-PAGE-based quantitative assay for screening of
kidney stone disease. Biol Proced Online. 11:145–160. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhuang T, Djemil T, Qi P, Magnelli A,
Stephans K, Videtic G and Xia P: Dose calculation differences
between Monte Carlo and pencil beam depend on the tumor locations
and volumes for lung stereotactic body radiation therapy. J Appl
Clin Med Phys. 14:40112013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ruan J, Mei L, Zhu Q, Shi G and Wang H:
Mixed lineage kinase domain-like protein is a prognostic biomarker
for cervical squamous cell cancer. Int J Clin Exp Pathol.
8:15035–15038. 2015.PubMed/NCBI
|
|
27
|
Wang H, Sun L, Su L, Rizo J, Liu L, Wang
LF, Wang FS and Wang X: Mixed lineage kinase domain-like protein
MLKL causes necrotic membrane disruption upon phosphorylation by
RIP3. Mol Cell. 54:133–146. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gallo KA and Johnson GL: Mixed-lineage
kinase control of JNK and p38 MAPK pathways. Nat Rev Mol Cell Biol.
3:663–672. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lotharius J, Falsig J, van Beek J, Payne
S, Dringen R, Brundin P and Leist M: Progressive degeneration of
human mesencephalic neuron-derived cells triggered by
dopamine-dependent oxidative stress is dependent on the
mixed-lineage kinase pathway. J Neurosci. 25:6329–6342. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chinchar E, Makey KL, Gibson J, Chen F,
Cole SA, Megason GC, Vijayakumar S, Miele L and Gu JW: Sunitinib
significantly suppresses the proliferation, migration, apoptosis
resistance, tumor angiogenesis and growth of triple-negative breast
cancers but increases breast cancer stem cells. Vasc Cell.
6:122014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Guidicelli G, Chaigne-Delalande B,
Dilhuydy MS, Pinson B, Mahfouf W, Pasquet JM, Mahon FX, Pourquier
P, Moreau JF and Legembre P: The necrotic signal induced by
mycophenolic acid overcomes apoptosis-resistance in tumor cells.
PLoS One. 4:e54932009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Vacratsis PO and Gallo KA: Zipper-mediated
oligomerization of the mixed lineage kinase SPRK/MLK-3 is not
required for its activation by the GTPase cdc 42 but is necessary
for its activation of the JNK pathway. Monomeric SPRK L410P does
not catalyze the activating phosphorylation of Thr258 of murine
MITOGEN-ACTIVATED protein kinase kinase 4. J Biol Chem.
275:27893–27900. 2000.PubMed/NCBI
|
|
33
|
Wang L, Gallo KA and Conrad SE: Targeting
mixed lineage kinases in ER-positive breast cancer cells leads to
G2/M cell cycle arrest and apoptosis. Oncotarget. 4:1158–1171.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Müller GJ, Geist MA, Veng LM, Willesen MG,
Johansen FF, Leist M and Vaudano E: A role for mixed lineage
kinases in granule cell apoptosis induced by cytoskeletal
disruption. J Neurochem. 96:1242–1252. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Mota M, Reeder M, Chernoff J and Bazenet
CE: Evidence for a role of mixed lineage kinases in neuronal
apoptosis. J Neurosci. 21:4949–4957. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Fang W, Jia ZS and Tong ZS: Research
progress in mixed lineage kinase domain-like. Sheng Li Ke Xue Jin
Zhan. 46:265–268. 2015.PubMed/NCBI
|
|
37
|
Garlena RA, Gonda RL, Green AB, Pileggi RM
and Stronach B: Regulation of mixed-lineage kinase activation in
JNK-dependent morphogenesis. J Cell Sci. 123:3177–3188. 2010.
View Article : Google Scholar : PubMed/NCBI
|
